Your browser doesn't support javascript.
loading
Preventing dementia by preventing stroke: The Berlin Manifesto.
Hachinski, Vladimir; Einhäupl, Karl; Ganten, Detlev; Alladi, Suvarna; Brayne, Carol; Stephan, Blossom C M; Sweeney, Melanie D; Zlokovic, Berislav; Iturria-Medina, Yasser; Iadecola, Costantino; Nishimura, Nozomi; Schaffer, Chris B; Whitehead, Shawn N; Black, Sandra E; Østergaard, Leif; Wardlaw, Joanna; Greenberg, Steven; Friberg, Leif; Norrving, Bo; Rowe, Brian; Joanette, Yves; Hacke, Werner; Kuller, Lewis; Dichgans, Martin; Endres, Matthias; Khachaturian, Zaven S.
Affiliation
  • Hachinski V; Department of Clinical Neurological Sciences, Western University, Ontario, Canada. Electronic address: Vladimir.hachinski@lhsc.on.ca.
  • Einhäupl K; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ganten D; Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Alladi S; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
  • Brayne C; Department of Public Health and Primary Care in the University of Cambridge, Cambridge, UK.
  • Stephan BCM; Institute of Mental Health, Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK.
  • Sweeney MD; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Zlokovic B; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Iturria-Medina Y; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
  • Iadecola C; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
  • Nishimura N; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
  • Schaffer CB; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
  • Whitehead SN; Department of Anatomy and Cell Biology, Western University, Ontario, Canada.
  • Black SE; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Østergaard L; Department of Clinical Medicine, Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark; Department of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
  • Wardlaw J; Centre for Clinical Brain Sciences, Edinburgh Imaging, UK Dementia Research Institute, University of Edinburgh, Scotland, UK.
  • Greenberg S; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Friberg L; Department of Clinical Sciences, Karolinska Institute, Stockholm, Sweden.
  • Norrving B; Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden.
  • Rowe B; Department of Emergency Medicine and School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
  • Joanette Y; Canadian Institute of Health and Research, Ottawa, Canada.
  • Hacke W; Department of Neurology, Heidelberg University, Heidelberg, Germany.
  • Kuller L; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Dichgans M; Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany.
  • Endres M; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany; ExcellenceCluster NeuroCure, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Center for Neur
  • Khachaturian ZS; Prevent Alzheimer Disease (PAD2020), Potamac, MD, USA.
Alzheimers Dement ; 15(7): 961-984, 2019 07.
Article in En | MEDLINE | ID: mdl-31327392
The incidence of stroke and dementia are diverging across the world, rising for those in low- and middle-income countries and falling in those in high-income countries. This suggests that whatever factors cause these trends are potentially modifiable. At the population level, neurological disorders as a group account for the largest proportion of disability-adjusted life years globally (10%). Among neurological disorders, stroke (42%) and dementia (10%) dominate. Stroke and dementia confer risks for each other and share some of the same, largely modifiable, risk and protective factors. In principle, 90% of strokes and 35% of dementias have been estimated to be preventable. Because a stroke doubles the chance of developing dementia and stroke is more common than dementia, more than a third of dementias could be prevented by preventing stroke. Developments at the pathological, pathophysiological, and clinical level also point to new directions. Growing understanding of brain pathophysiology has unveiled the reciprocal interaction of cerebrovascular disease and neurodegeneration identifying new therapeutic targets to include protection of the endothelium, the blood-brain barrier, and other components of the neurovascular unit. In addition, targeting amyloid angiopathy aspects of inflammation and genetic manipulation hold new testable promise. In the meantime, accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles (e.g., reduced prevalence of smoking) and vascular disease, including stroke, have better cognitive function and lower dementia rates. At the individual levels, trials have demonstrated that anticoagulation of atrial fibrillation can reduce the risk of dementia by 48% and that systolic blood pressure lower than 140 mmHg may be better for the brain. Based on these considerations, the World Stroke Organization has issued a proclamation, endorsed by all the major international organizations focused on global brain and cardiovascular health, calling for the joint prevention of stroke and dementia. This article summarizes the evidence for translation into action.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation / Brain / Stroke / Dementia / Hypertension Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Dement Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation / Brain / Stroke / Dementia / Hypertension Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Dement Year: 2019 Type: Article